IGM Biosciences, Inc.
IGMS
$1.25
$0.054.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 152.11M | 183.79M | 218.79M | 256.38M | 293.77M |
| Total Receivables | 900.00K | 800.00K | 1.00M | 900.00K | 900.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.03M | 8.87M | 9.65M | 8.45M | 7.76M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 167.00K | 190.00K | 289.00K | 325.00K |
| Total Current Assets | 161.04M | 193.62M | 229.63M | 266.02M | 302.75M |
|
|
|||||
| Total Current Assets | 161.04M | 193.62M | 229.63M | 266.02M | 302.75M |
| Net Property, Plant & Equipment | 45.02M | 71.03M | 73.74M | 69.05M | 71.77M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 827.00K | 1.06M | 1.14M | 1.43M | 1.61M |
| Total Assets | 206.89M | 265.71M | 304.51M | 336.50M | 376.13M |
|
|
|||||
| Total Accounts Payable | 1.30M | 983.00K | 3.55M | 3.26M | 4.00M |
| Total Accrued Expenses | 17.13M | 26.88M | 31.07M | 26.46M | 23.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.02M | 7.12M | 6.70M | 5.94M | 6.63M |
| Total Finance Division Other Current Liabilities | 2.75M | 2.65M | 2.65M | 2.00M | 3.66M |
| Total Other Current Liabilities | 2.75M | 2.65M | 2.65M | 2.00M | 3.66M |
| Total Current Liabilities | 28.20M | 37.64M | 43.96M | 37.66M | 37.93M |
|
|
|||||
| Total Current Liabilities | 28.20M | 37.64M | 43.96M | 37.66M | 37.93M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 36.94M | 38.07M | 39.16M | 33.44M | 34.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 141.05M | 141.84M | 142.44M | 143.05M | 142.65M |
| Total Liabilities | 206.19M | 217.54M | 225.56M | 214.14M | 214.88M |
|
|
|||||
| Common Stock & APIC | 1.07B | 1.07B | 1.06B | 1.04B | 1.03B |
| Retained Earnings | -1.07B | -1.02B | -980.39M | -918.96M | -871.06M |
| Treasury Stock & Other | 85.00K | 159.00K | 421.00K | -195.00K | -128.00K |
| Total Common Equity | 698.00K | 48.17M | 78.95M | 122.36M | 161.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 698.00K | 48.17M | 78.95M | 122.36M | 161.25M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 698.00K | 48.17M | 78.95M | 122.36M | 161.25M |
|
|
|||||